Ryan Mee, CEO of Fulcrum Metals, reviews FY23 and progress on the Gold Tailings Hub in Canada. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTransense Regulatory News (TRT)

Share Price Information for Transense (TRT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 107.00
Bid: 106.00
Ask: 108.00
Change: 4.50 (4.39%)
Spread: 2.00 (1.887%)
Open: 102.50
High: 107.00
Low: 102.50
Prev. Close: 102.50
TRT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Interim Results & Investor Presentation

22 Feb 2023 07:00

RNS Number : 6303Q
Transense Technologies PLC
22 February 2023
 

The information contained within this announcement is deemed by the Company to constitute inside information pursuant to Article 7 of EU Regulation 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 as amended.

 

22 February 2023

Transense Technologies plc

("Transense" or the "Company")

 

Interim Results & Investor Presentation

 

Transense Technologies plc, the developer of specialist sensor systems, reports its unaudited Interim Results for the six months ended 31 December 2022. The Company continued to deliver robust growth in revenues and profitability in line with the Board's expectations, and reports further strengthening in current trading and a positive outlook.

Financial Highlights:

Revenue increased by 37% to £1.64m (FY22 H1: £1.20m)

EBITDA up 80% to £0.36m (FY22 H1: £0.20m)

Profit before taxation up threefold to £0.26m (FY22 H1: £0.08m)

Earnings per share of 2.50 pence (FY 22 H1: 0.69 pence)

Net cash at 31 December 2022 of £0.63m (30 June 2022: £1.05m); cash at 17 February 2023 has increased to £1.28m

Accelerated growth in revenue and profitability since period end

Surface Acoustic Wave (SAW) highlights:

Increased pipeline of potential SAW customer engagements to 40 at February 2023 (September 2022: 24)

Signed Memorandum of Understanding with Parker Meggitt; work progressing

Gained external verification of significant efficiency improvements in electric motor control

Commenced funded development project with major Tier One aerospace client

Passed gateway review to Phase 2 of UK's Advanced Propulsion Centre grant funded development programme

Commenting on the results and prospects, Executive Chairman of Transense, Nigel Rogers, said:

"Transense continues on its upward trajectory, with significant growth across all three income streams. Trading since the period end has been strong, and the pipeline development across the business, especially in SAW, gives us every reason to be confident in the future."

 

Investor Presentation: 4pm today, Wednesday 22 February 2022

Nigel Rogers (Executive Chairman), Melvyn Segal (Chief Financial Officer) and Ryan Maughan (Business Development Director) will provide a presentation on the Company and its Interim Results at 4pm today, Wednesday 22 February 2023. The presentation will be hosted through the digital platform Investor Meet Company.

To attend the presentation, investors can sign up to Investor Meet Company for free and select to meet Transense Technologies plc via the following link: https://www.investormeetcompany.com/transense-technologies-plc/register-investor. Investors who have already registered and selected to meet the Company will automatically be invited to the presentation.

Questions can be submitted before the event to transense@walbrookpr.com, or in real time during the presentation via the "Ask a Question" function. 

This Interim Results report will not be posted to shareholders but will be available on the Company's website later today along with the investor presentation.

 

 

For further information please visit www.transense.com or contact:

Transense Technologies plc

Nigel Rogers (Executive Chairman)

Melvyn Segal (CFO)

Via Walbrook PR

Allenby Capital (Nominated Adviser and Broker)

Jeremy Porter/George Payne (Corporate Finance)

Tony Quirke (Sales and Corporate Broking)

Tel: +44 (0)20 3328 5656

Walbrook PR

Tom Cooper/Nick Rome/Joe Walker

Tel: +44 (0)20 7933 8780

Transense@walbrookpr.com

 

Notes to Editors:

Transense is headquartered in Oxfordshire, UK and its shares are traded on AIM, a market operated by the London Stock Exchange (AIM: TRT). The Company develops and supplies wireless sensor technology and systems, and currently has three business segments:

SAW - patent protected Surface Acoustic Wave sensor technology that provides real time measurement of torque, temperature, pressure and strain, and is used to improve efficiency, performance, safety and sustainability of propulsion systems and machinery. Current focus is the development of a pipeline of high calibre customers and collaborative partnerships for a variety of applications in electric drives, aerospace, industrial machinery (including off-highway and robotics) and high performance automotive sectors.

Translogik - smart, connected commercial vehicle tyre inspection equipment, used by vehicle fleets to more easily gather and maintain accurate tyre safety and condition data; and,

iTrack - a tyremonitoring system for off-highway vehicles, licensed exclusively to Bridgestone Corporation, the world's largest tyre producer, under a ten-year deal expiring in 2030.

For further information please contact transense@walbrookpr.com

 

 

Transense Technologies plc - Interim Results for the half year ended 31 December 2022

Chairman's statement

It is pleasing once again to report healthy results, with increased revenue and profits across all areas of the business, and the achievement of further important milesones in building the longer term value proposition from our SAW technology. 

Business strategy

The business strategy of the Company remains to develop innovative sensing solutions across a range of applications, which are commercialised either through the launch of products and services to customers or by forming strategic alliances with partner organisations. Value is realised through a combination of commercial income, royalties, licensing income and capital gains on disposals.

Business review

iTrack royalty income

iTrack royalty income for the period amounted to £0.97m, which represented an increase of 47% compared with the equivalent period last year (FY22 H1: £0.66m). During the six months ended 31 December 2022, the iTrack installed base grew at a more modest rate than had previously been experienced, with the annualised royalty run rate in Sterling terms increasing by nearly 25% in the last 12 months, to reach £1.97m per annum (31 December 2021: £1.57m). The Board considers this reduced rate of growth to be principally attributable to delays in implementation by end users, however, the sales pipeline at the end of the period was strong. This was evidenced by the conversion of two major accounts towards the end of the period which are currently in the process of installing iTrack. 

Surface Acoustic Wave (SAW)

There are clear signs of increasing traction in the commercialisation of SAW technology. During the period SAW revenues (including grant income) more than doubled to £0.17m (FY22 H1: £0.07m). The pipeline of potential customers and partners has increased substantially since last year's final results were reported in September 2022, and now stands at 40 (September 2022: 24). Our activities are focused on four key target market sectors:

Aerospace

Aerospace applications have been generating interest where torque measurement is required in several applications across the sector. Our SAW technology continues to offer advantages over other technologies due to its accuracy, robustness and compact size and weight, the benefits of which will be to improve efficiency, safety, pilot control and engine reliability.

Under the non-exclusive licence agreed in 2016, GE Aviation's testing of the first T901 engine under the ITEP programme has been very successful, with the engine accumulating more than 100 hours of run time with impressive performance and condition. A second engine build is under preparation and this unit will enter testing in 2023.  We are continuing to support the development phase of GE's Hybrid Electric Altitude Testbed flight demonstrator (HEAT) programme, and our technology is under consideration for other engine development work.

During the period, the Company entered a Memorandum of Understanding (MoU) with Meggitt SA, now Parker Meggitt, part of the Parker Hannifin Corporation, with the shared aim to enter into a licensing agreement prior to 31 December 2023 covering one or more fields of use in aerospace. Good progress has been made already and the preparation phase of this work is complete, enabling engagement with potential customers in the second half of our financial year.

We are also free to continue to engage independently with a number of leading Original Equipment Manufacturers (OEM) and Tier One (T1) technology providers to explore potential aerospace applications during this phase of the MoU. There is significant interest across a broad range of applications, extending beyond engines to other areas including, for example, actuation and braking systems. Since the period end, we have commenced a paid feasibility study with another major T1 to evaluate the potential use of SAW, with early-stage discussions underway with a number of potential customers to identify further similar projects. The Company is now actively engaged with a combined total of 10 aerospace OEMs and T1s each at various stages of testing, assessment and discussions.

Electric motors and drives (EMD)

The electric motor and drive systems market is a large and rapidly growing sector due to the widespread electrification of vehicles and the desire to improve range and performance. Transense SAW technology can enable the direct measurement of output torque to improve performance, efficiency, and safety in electric motor drive systems.

Transense successfully passed the stage gate assessment process to enter the second phase of the UK's Advanced Propulsion Centre TDAP (Technology Developer Accelerator Programme). Our aims for this stage are:

· Continued market engagement, working with automotive OEMs and Tier 1 and 2 suppliers to help them understand the benefits of SAW technology. The Company has increased engagement to 18 organisations in this sector, with opportunities beginning to progress through to customer funded trials and design-in projects, and is working to increase this in the second half of the financial year;

· Characterising the benefits of SAW sensing technology in an electric motor drive system. The Company commissioned a simulation study by expert consultancy Drive System Design Ltd. The first 2 stages of this study are complete and show strong potential to achieve significant improvements in efficiency and performance by using active torque feedback in the electric motor control system;

· Developing the manufacturing and calibration processes to demonstrate improved capability, reduced costs and a clear route to higher volumes. The Company has identified a plan of work and the internal and external resources required to deliver it; and

· Developing the supply chain for key components to secure a clear route to higher volumes.

The process improvement and supply chain activity also has benefits for the exploitation of SAW technology in other sectors.

Industrial machinery

Industrial machinery covers a huge range of applications from off-highway construction and agricultural equipment to manufacturing and warehouse robots. Torque and force sensing is already used today in some industrial machinery applications such as collaborative robots. The demand to improve machine performance and increase automation is leading to requirements for more capable sensing systems not possible with conventional sensing technology. SAW technology can create robust and reliable smart components with improved sensing functionality that can be integrated into advanced machines and systems to provide highly accurate sensing.

Transense has increased engagement to 11 industrial machinery manufacturers with opportunities beginning to progress through to customer funded trials and design-in projects, thanks to increased awareness of the technology and its capabilities. Transense is also seeing regular new enquiries from industrial machinery manufacturers. The Company will continue to promote the technology and its benefits to this market and develop opportunities with leading OEMs and T1s in this sector.

Performance automotive

The performance automotive market continues to offer a high-profile proving ground for our SAW technology which may subsequently be adopted in mainstream vehicles. There is strong overlap with EMD as high volume performance vehicles are increasingly being developed using an electric drivetrain.

Our five-year Joint Collaborative Agreement (JCA) with McLaren Applied in premium motor sport, signed in September 2021, delivered increased revenue in the period as SAW technology extended beyond the IndyCar race series into Le Mans Daytona hybrid (LMDh), with pleasing results and positive feedback. Opportunities to augment the reach into other race series and beyond into high performance road cars are under consideration, as well as seeking opportunities in other McLaren Applied niche markets.

Pipeline development

The Company has implemented a pipeline management process to create visibility of opportunities and their stage of development, divided into the four key focus markets above (aerospace, electric motors and drives, industrial machinery, and performance automotive). Opportunities are qualified against agreed criteria and progressed accordingly.

The Company has created marketing assets aimed at communicating the benefits of the technology in key applications in the focus markets. As well as an increased online presence, the Company has attended several key trade shows and conferences. This targeted marketing approach has yielded significantly improved quality and quantity of inbound enquiries. Due to this success, the Company will continue online content creation and promotion activity and also increase the number of physical events attended in the next period.

The number of potential customers engaged, from active enquiry through to contract, at February 2023 (September 2022) was as follows:

Aerospace

Electric motors and drives

Industrial machinery (incl OTR & Agric)

Performance automotive

Total

Stage 4 - Contracted

1 (1)

0 (0)

0 (0)

1 (1)

2 (2)

Stage 3 - Contract under negotiation

1 (1)

0 (0)

0 (0)

0 (0)

1 (1)

Stage 2 - In development

2 (1)

1 (1)

1 (1)

0 (0)

4 (3)

Stage 1 - Active enquiry

6 (4)

17 (10)

10 (4)

0 (0)

33 (18)

 

Total

 

10 (7)

 

18 (11)

 

11 (5)

 

1 (1)

 

40 (24)

 

The substantial increase in the number of potential customers engaged from 24 to 40 is encouraging, and endorses the relevance of SAW technology in our key target markets. It must be recognised that progressing this initial interest into funded development activity can take time, as it is dependent upon commercial and engineering support within customer organisations as well as budget allocation and approval. Accordingly, we must continue to be realistic when assessing the likelihood and timing of recurring revenue generation from these activities. Once converted, however, there are realistic prospects of long term success deriving from delivering a unique solution that can offer high value outcomes for our customers and partners.

Translogik tyre monitoring probes

The modular TLGX Series range currently offers four levels of probe technology, offering progressively enhanced features at a variety of price points, and has now replaced the original TLG Generation One probe.

The TLGX Series provides extremely accurate, reliable and instant tyre data, ranging from simple tread depth readings through to the TLGX4, which provides tread depth and the facility to read RFID tags and tyre pressure sensors remotely. The range is principally aimed towards service providers, systems integrators and fleet managers in the truck and bus sector. The product range is designed to be compatible with the tyre management systems of most of the world's leading tyre producers.

Revenue from Translogik probes increased by 11% to £0.52m (FY22 H1: £0.47m), with gross margin increasing to 57% from 54% of revenue as the new range becomes fully established.

The global shortage of electronic components has been a challenge, but due to our ability to act quickly to adopt innovative design changes, product availability has not impacted sales and we are confident that we have sufficient inventories to meet the strong current pipeline of demand for the second half of the year.

We are also experiencing increased enquiries from fleet management system software providers who are recognising the qualities of our probe, enabling them to provide a fully digital fleet management system which provides improved efficiency, audit trail and meets increasingly demanding regulatory standards around the world.

Financial review

 

Financial results

 

Revenues for the six months increased by 37% to £1.64m (FY22 H1: £1.20m).

Royalty income generated by iTrack technology increased by 47% to £0.97m (FY22 H1: £0.66m). The installed base increased by 195% since inception of the contract. The annualised royalty run rate at 31 December 2022 was£1.97m, 207% higher than the opening US Dollar run rate in June 2020, or in Sterling terms a similar increase of 209%. Translogik probe revenues increased by 11% to £0.52m, with improved margins the gross profit has increased by 16%.

SAW revenues doubled to £0.14m for the period (FY22 H1: £0.07m). Whilst SAW activities continue to incur a net loss, the Board is satisfied that it is appropriate to continue to allocate capital to developing this business in recognition of the prospects of future commercial success.

Operating expenses in the period increased to £1.18m (FY22 H1: £0.90m). The year on year increase mainly reflects increased salary costs as a result of additional head count in the SAW team, and a net foreign exchange loss resulting from forward contracts purchased to hedge the iTrack royalty income at $1.23 to £1 during the first half of the year. The contracted rates for the second half are $1.17 to £1, and at current exchange rates these are expected to generate a foreign exchange gain in the second half of the financial year.

EBITDA increased by 82% to £0.36m (FY22 H1: £0.20m), and net profit before taxation was £0.26m (FY22 H1: £0.08m). After recognition of deferred tax, the net profit after taxation attributable to shareholders was £0.40m (FY22 H1: £0.11m) and earnings per share amounted to 2.50 pence (FY22 H1: 0.69 pence).  

Key performance indicators (KPI)

 

The Board considers the following to be the key performance indicators for the Company:

 

FY 2023

FY 2022

Interim

(unaudited)

Interim

(unaudited)

Full Year

(audited)

Revenue (£m)

1.64

1.20

2.63

iTrack royalty run rate growth YoY (in USD)

15%

122%

46%

Translogik probe revenue growth YoY

11%

15%

14%

SAW revenue growth YoY

100%

(36)%

28%

EBITDA (£m)

0.36

0.20

0.52

EPS (pence)

2.50

0.69

0.96

Available cash balances (£m)

0.63

1.07

1.06

Distributable reserves (£m)

1.45

0.74

1.20

Average share price in period (pence)

72.9

99.3

85.5

Cash flow and financial position

Net cash inflow from operating activities before movements in working capital amounted to £0.42m (FY22 H1: £0.24m).  There was a planned net investment in working capital which totalled £0.59m in the period, the largest proportion being in support of inventory build for Translogik probes, and the generation of increased receivables from both iTrack and Translogik. The Company also funded the repurchase of treasury shares amounting to £0.15m during the period.

Net cash balances at the end of the period stood at £0.62m (30 June 2022: £1.07m). The net investment in working capital peaked around the period end, and will unwind through the first quarter of 2023. The net cash balance at 17 February 2023 increased to £1.28m, which reflects the post period collection of receivables (including iTrack royalties for the final quarter of calendar year 2022) and the settlement of the related foreign exchange forward contract.

The Board has assessed the financial and operational needs of the business over the next twelve months, taking into account a range of contingencies, and the Directors are satisfied that the Company has access to adequate sources of finance. Accordingly, the Board considers that the Company will have sufficient resources to continue in operational existence for the foreseeable future, and has adopted the going concern basis of accounting.

Capital allocation and distribution policy

The Company's share price over the period rose from 62.5p on 1 July 2022 to a peak of 95.5p on 30 November 2022 and closed the period on 31 December 2022 at 87.5p. The recent share price as at 20 February 2023 stood at 93.0p.

Capital is allocated by the Board with the aim of maximising long term shareholder returns. Profits generated from iTrack and Translogik are first applied to meet the Company's unallocated overhead expenses and net investment in the continuing development of the SAW business. It is anticipated that a surplus will be generated from these trading activities, which will be allocated to the retention of earnings in the business for long term investment, and for distribution to shareholders.

In April 2022, the Company commenced a share buyback programme and in the prior financial year acquired 434,000 treasury shares at an average price of 70 pence per share. In the period to 31 December 2022 a further 170,027 shares were purchased at an average price of 89 pence per share, resulting in the Company holding 604,027 treasury shares at an average price of 75 pence per share at the period end.

The Board has authority from shareholders to continue the programme to acquire up to 500,000 further shares for treasury to continue to offset the dilutive impact of share awards to Directors and employees in due course, and where market conditions deem such action to be appropriate.

The Board has also previously indicated an intention to consider commencing the payment of dividends and will provide further guidance around the end of this financial year.

Current trading and outlook

Trading in the month following the period end has seen both SAW and Translogik deliver strong revenues. There are indications that the iTrack royalty pipeline should return to higher growth in calendar 2023.  Overall, the Board's outlook for the remainder of this year is positive and the Directors expect the Company to meet its expectations for the financial year.

Looking further forward, the Board is greatly encouraged by the depth and quantity of engagement with leading companies across the four key high growth market sectors for SAW. These interactions give us continued optimism that we can forge lasting partnerships and fulfil the undoubted potential that our technology demonstrates.

Nigel RogersExecutive Chairman22 February 2023

 

Transense Technologies plc

Condensed Statement of Comprehensive Income

Half year to

Half year to

Full year to

31 Dec 22

31 Dec 21

30 Jun 22

(Unaudited)

(Unaudited)

(Audited)

£'000

£'000

£'000

Continuing operations

Revenue

1,638

1,203

2,632

Cost of sales

(227)

(217)

(398)

Gross profit

1,411

986

2,234

Operating expenses

(1,180)

(898)

(1,970)

Operating profit

231

88

264

Financial expense/income

2

(6)

(12)

Other income

24

-

16

Profit before taxation

257

82

268

Taxation

142

32

609

Profit for the period from continuing operations

399

114

877

Earnings per share (pence)

2.50

 

0.69

 

5.36

 

Transense Technologies plc

Condensed Statement of Financial Position

31 Dec 22

31 Dec 21

30 Jun 22

(Unaudited)

(Unaudited)

(Audited)

£'000

£'000

£'000

Non current assets

Property, plant and equipment

159

201

167

Intangible assets

645

731

671

Deferred tax

787

68

645

1,591

1,000

1,483

Current assets

Inventory

315

108

88

Corporation tax receivable

-

71

-

Trade and other receivables

1,300

731

1,133

Cash and cash equivalents

625

1,071

1,055

2,240

1,981

2,276

Total assets

3,831

2,981

3,759

Current liabilities

Trade and other payables

(363)

(269)

(560)

Lease liabilities

(63)

(63)

(65)

Total liabilities

(426)

(332)

(625)

Non current liabilities

Lease liabilities

(7)

(75)

(42)

Total liabilities

(433)

(407)

(667)

Net assets

3,398

2,574

3,092

Capital and reserves

Share capital

1,644

1,644

1,644

Share premium

65

65

65

Treasury Shares

(455)

-

(303)

Share based payments

239

122

180

Retained profit

1,905

743

1,506

Shareholders' funds

3,398

2,574

3,092

 

  

 

Transense Technologies plc

Condensed Statement of Changes in Equity (Unaudited)

 

Share capital

Share premium account

Share based payments

Retained earnings

 

Treasury Shares

Total equity

£'000

£'000

 

£'000

£'000

£'000

£'000

Balance at 1 July 2021

1,631

-

82

629

-

2,342

Comprehensive income for the year:

Profit for the year

-

-

-

877

-

877

Share based payment

-

-

98

-

-

98

Warrants exercised

13

65

-

-

-

78

Treasury Shares

-

-

-

-

(303)

(303)

Balance at 30 June 2022

1,644

65

180

1,506

(303)

3,092

Comprehensive income for the period

 

Profit for the period

-

-

-

399

-

399

Share based payment

-

-

59

-

-

59

Treasury Shares

-

-

-

-

(152)

(152)

Balance at 31 December 2022

1,644

65

239

1,905

(455)

3,398

 

 

Transense Technologies plc

Condensed Statement of Cash Flows

Half year to

Half year to

Full year to

31 Dec 22

31 Dec 21

30 Jun 22

(Unaudited)

(Unaudited)

(Audited)

£'000

£'000

£'000

Cash flow from operating activities

Profit for the period

399

114

877

Adjustments for:

Taxation

(142)

(32)

(609)

Net financial expense/income

(2)

6

12

Depreciation of property, plant and equipment

47

43

88

Amortisation and impairment of intangible assets

58

65

155

Share based payments

59

40

98

Operating cash flows before movements in working capital

419

236

621

Change in receivables

(167)

(167)

(569)

Change in payables

(197)

9

300

Change in inventories

(227)

(35)

(15)

Cash used in operations

(172)

43

337

Taxation recovered

-

-

71

Net cash (used)/generated in operations

(172)

43

408

Cash flows from investing activities

Acquisition of property, plant & equipment

(39)

(33)

(44)

Acquisition of intangible assets

(32)

(25)

(56)

Net cash used in investing activities

(71)

(58)

(100)

Cash flows from financing activities

Warrants exercised

-

78

78

Treasury shares

(152)

-

(303)

Interest paid

2

(6)

(12)

Payment of lease liabilities

(37)

(31)

(62)

Net cash (used)/generatedfor financing activities

(187)

41

(299)

Net (decrease)/increase/ in cash and cash equivalents

(430)

25

9

Cash and cash equivalents at beginning of period

1,055

1,046

1,046

Cash and cash equivalents at end of period

625

1,071

1,055

 

 

Notes to the Interim results for the six months to 31 December 2021 

1. Reporting Entity and Basis of Preparation

Transense Technologies plc ("the Company") is a company incorporated in the United Kingdom under the Companies Act 2006. These condensed interim financial statements are presented in pounds sterling, rounded to the nearest thousand.

 

The financial statements of the Group are available upon request from the Company's registered office or at www.transense.com

 

2. Going Concern

The Board has considered the financial position and future plans of the Company and is satisfied that the Company will have adequate resources to continue in operational existence for the foreseeable future. Accordingly, these interim financial statements have been prepared on a going concern basis.

 

3. Accounting policies

The Condensed Financial Statements for the half yearly report for the six months ended 31 December 2022 have been prepared using accounting policies and methods of computation consistent with those set in Transense Technologies plc's Annual Report and Financial Statements for the year ended 30 June 2022. There has been no change to any accounting policy since the date of that report.

 

4. Segmental analysis

 

Revenue by region

Half year

to 31 Dec 22

Half year to 31 Dec 21

Full year to 30 Jun 22

 

(Unaudited)

(Unaudited)

(Unaudited)

 

£'000

£'000

£'000

North America

219

211

323

South America

89

64

123

Australia

23

18

41

UK & Europe

275

226

387

Rest of the World

57

24

109

Royalty Income

975

660

1,557

Total

1,638

1,203

2,540

 

Half Year to 31 Dec 2022

IT Royalties

£'000

SAW

£'000

Probes

£'000

Admin

£'000

Total

£'000

Turnover

975

143

520

-

1,638

Gross profit

975

138

298

-

1,411

Operating costs

-

(582)

(78)

(415)

(1,075)

EBITDA*

975

(444)

220

(415)

336

Depreciation and amortisation

(22)

(57)

-

(26)

(105)

Other Income

-

24

-

-

24

Finance expenses/income

-

2

-

-

2

Profit/(loss) before taxation

953

(475)

220

(441)

257

Taxation

-

-

-

142

142

Profit/(loss) after taxation

953

(475)

220

(299)

399

 

Half Year to 31 Dec 2021

IT Royalties

£'000

SAW

£'000

Probes

£'000

Admin

£'000

Total

£'000

Turnover

660

73

470

-

1,203

Gross profit

660

70

256

-

986

Operating costs

-

(411)

(62)

(317)

(790)

EBITDA*

660

(341)

194

(317)

196

Depreciation and amortisation

(22)

(57)

(29)

(108)

Finance expenses

-

-

-

(6)

(6)

Profit/(loss) before taxation

638

(398)

194

(352)

82

Taxation

5

6

-

21

32

Profit/(loss) after taxation

643

(392)

194

(331)

114

 

Year to 30 June 2022

IT Royalties

£'000

SAW

£'000

Probes

£'000

Admin

£'000

Total

£'000

Turnover

1,557

200

875

-

2,632

Gross profit

1,557

193

484

-

2,234

Operating costs

-

(871)

(126)

(729)

(1 ,726)

Other income

-

16

-

-

16

EBITDA*

1,557

(662)

358

(729)

524

Depreciation and amortisation

(44)

(142)

-

(58)

(244)

Finance expenses

-

-

-

(12)

(12)

Profit/(loss) before taxation

1,513

(804)

358

(799)

268

Taxation

-

-

-

609

609

Profit/(loss) after taxation

1,513

(804)

358

(190)

877

 

*Earnings before interest, tax, depreciation and amortisation

Note: The presentation of segmental information has been changed in the current period. The Directors have determined that it is more appropriate to include premises and other establishment costs in Central Overheads rather than in SAW activity as previously stated. Prior period information has been restated to be consistent with the current period.

5. Corporation tax and deferred tax

The Company has approximately £23m of Corporation Tax losses which, subject to agreement by HM Revenue and Customs, are available for offset against future profits of the same trade. There is no expiry date for tax losses, however, there is an annual restriction of £5m plus half of the surplus above £5m. As the Company moved into profitability, Deferred Tax was recognised for the first time in the full years accounts to 30 June 2021 by recognising a credit relating to FY22 estimated results. In the accounts for the year to 30 June 2022, the Deferred Tax credit was extended to reflect the estimated results for the following 24 months and the credit in these Interim accounts has been calculated on a consistent basis looking ahead 24 months.

 

The deferred tax charge and credit in H1 reflects the charge reversing the credit for the pre tax profit in H1 and an additional credit reflecting the forecast pre tax profits for the full year FY23, FY24 and 6 months of FY25. This policy reflects the fact that the Company now has a trend of underlying profitability.

6. Earnings per share

 

31 December 2022

31 December 2021

30 June 2022

Shares

Shares

Shares

Weighted average number of shares in the period

15,962,643

16,402,998

16,365,640

Basic and diluted Earnings per share

2.50p

0.69p

5.36p

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IR MZGZZGMMGFZZ
Date   Source Headline
1st May 20247:00 amRNSDirector/PDMR - Acquisition of Shares
30th Apr 20245:00 pmRNSTotal Voting Rights
30th Apr 20247:00 amRNSTRT joins £37.8m LANDOne project with Airbus & ATI
17th Apr 20246:00 pmRNSTransaction in Own Shares & TVR
15th Apr 20242:51 pmRNSTransaction in Own Shares & TVR
28th Mar 20245:00 pmRNSTotal Voting Rights
25th Mar 20243:35 pmRNSTransaction in Own Shares & TVR
20th Mar 20249:10 amRNSRyan Maughan appointed as Managing Director
29th Feb 20245:00 pmRNSTotal Voting Rights
21st Feb 20242:40 pmRNSHolding(s) in Company
19th Feb 20247:00 amRNSInterim Results & Investor Presentation
15th Feb 20247:00 amRNSHolding(s) in Company
2nd Feb 20245:41 pmRNSTransaction in Own Shares & TVR
31st Jan 20245:00 pmRNSTotal Voting Rights
12th Jan 20247:00 amRNSDirector/PDMR Shareholding
11th Jan 20249:52 amRNSTransaction in Own Shares & TVR
8th Jan 20247:00 amRNSTranslogik Update – Appointment of Sales Director
1st Dec 20237:00 amRNSGrant of share options to Director and employee
30th Nov 20235:00 pmRNSTotal Voting Rights
30th Nov 202311:11 amRNSDirector/PDMR Shareholding
29th Nov 20233:01 pmRNSDirector/PDMR Shareholding
29th Nov 202310:45 amRNSResult of AGM
29th Nov 20237:00 amRNSAGM Statement & Trading Update
24th Nov 20231:11 pmRNSHolding(s) in Company
9th Nov 202312:12 pmRNSDirector/PDMR Shareholding
6th Nov 20234:48 pmRNSTransaction in Own Shares & TVR
25th Oct 202310:00 amRNSPosting of Annual Report & Notice of AGM
16th Oct 20233:23 pmRNSHolding(s) in Company
3rd Oct 20236:00 pmRNSHolding(s) in Company
28th Sep 20235:22 pmRNSHolding(s) in Company
27th Sep 20233:18 pmRNSHolding(s) in Company
26th Sep 20233:37 pmRNSDirector/PDMR Shareholding
25th Sep 202311:00 amRNSDirector/PDMR Shareholding
25th Sep 20237:00 amRNSFinal Results & Investor Presentation
22nd Sep 20239:25 amRNSHolding(s) in Company
31st Aug 20235:00 pmRNSTotal Voting Rights
29th Aug 20238:30 amRNSTransaction in Own Shares & TVR
23rd Aug 20237:00 amRNSNotice of Results & Investor Presentation
16th Aug 202310:03 amRNSHolding(s) in Company
11th Jul 20237:00 amRNSYear End Trading Update
30th Jun 20235:00 pmRNSTotal Voting Rights
22nd Jun 20234:24 pmRNSTransaction in own shares & TVR
19th Jun 20234:29 pmRNSHolding(s) in Company
16th Jun 20235:57 pmRNSTransaction in own shares & TVR
5th Jun 20237:00 amRNSSAW: Extension of scope of licence agreement
2nd Jun 20232:36 pmRNSTransaction in own shares & TVR
31st May 20235:00 pmRNSTotal Voting Rights
3rd May 20237:00 amRNSNew Automotive eDrive Business Contract
2nd May 202312:48 pmRNSAppointment of Non-Executive Director
2nd May 202310:23 amRNSTransaction in own shares & TVR

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.